Andrew D.c. LaFrence is CFO at Vyant Bio, Inc. (VYNT). They have made 2 open-market trades across 1 company since 2021, most recently 2026-06-10.
CIK 0001850633
2 open-market purchases totalling $20K since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.